EPISODE · Aug 29, 2025 · 4 MIN
VC가 한발 물러설 때 바이오 기업의 대체 자금원은? (Korean-language podcast)
from Citeline Podcasts · host Norstella
전통적 벤처캐피털이 점점 더 신중하고 선별적인 투자 성향으로 변하면서 바이오 기업들이 새로운 자본 조달 경로를 모색하고 있다는 Citeline의 In Vivo 기사를 요약한 내용입니다. https://insights.citeline.com/in-vivo/growth/when-vc-steps-back-finding-alternative-biotech-funding-4UN5IYJEUZD2XPLYIZ7RR7YVQY/ Playlist: https://soundcloud.com/citelinesounds/sets/korean-language-biopharma-mini
Embed this episode
Ready to play
VC가 한발 물러설 때 바이오 기업의 대체 자금원은? (Korean-language podcast)
0:00
4:30
1×
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
Frequently Asked Questions
How long is this episode of Citeline Podcasts?
This episode is 4 minutes long.
When was this Citeline Podcasts episode published?
This episode was published on August 29, 2025.
Can I download this Citeline Podcasts episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!